DNA methyltransferase (DNMT) and enhancer of zeste homolog 2 (EZH2) can mediate DNA methylation and histone lysine methylation, respectively, to suppress the expression of CXCL9 and CXCL10 in ovarian cancer 48. This evidence concerns the gene EZH2 and ovarian carcinoma.